Retro Review: Joe Ferguson gets his hands on the iconic TaylorMade RBZ fairway wood from 2012, which launched with bold claims of an additional 17 yards! So we wanted to put this to the test to see ...

In the age where video game adaptations are finally being given the justice and due diligence they deserve, Netflix has practically had the market cornered when it comes to animation. With a long list ...

As an Amazon Associate, we earn from qualifying purchases. TweakTown may also earn commissions from other affiliate partners at no extra cost to you. The MSI Stealth A16 AI+ is a unicorn laptop that ...

After a tumultuous journey filled with delays and rejection, the FDA has approved Stealth BioTherapeutics’ treatment for the ultrarare disease Barth syndrome, marking the peptide as the first therapy ...

The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for elamipretide in the treatment of Barth syndrome, a rare mitochondrial disease.

Think of a stealth game, and an image of its protagonist quickly takes shape; they're surrounded by tremendous danger, equipped with a limited arsenal, and have to stay crouched in the shadows to ...

The B-2s, valued at roughly $2 billion a piece, are known not only for their stealth technology, but for their ability to fly long range. Its design and materials limit its ability to be detected by ...

The Turtle Beach Stealth 600 is a smashing mid-range wireless gaming headset. I wish the sound isolation was more impressive, and the lack of floating headband really grinds my gears considering ...

Stealth BioTherapeutics’ 16.5-month priority review cycle has ended in rejection. After delays, Stealth said the FDA turned down its request but set out a path to accelerated approval, leading the ...

What if you could hold the future of computing in your hands—without feeling like you’re carrying a brick? The MSI Stealth 18 HX AI is rewriting the rules of what a high-performance laptop can be.

An approval decision for Stealth BioTherapeutics’ investigational treatment for an ultra-rare genetic disease has been delayed—again—this time, with no new decision date given. The biotech’s candidate ...